Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft
- 1 March 2018
- journal article
- research article
- Published by Elsevier in The Spine Journal
- Vol. 18 (3) , 439-446
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusionThe Spine Journal, 2013
- Transforaminal Lumbar Interbody Fusion With rhBMP-2 in Spinal Deformity, Spondylolisthesis, and Degenerative Disease—Part 2Spine, 2013
- Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous systemThe Spine Journal, 2011
- Trends in the Use of Bone Morphogenetic Protein as a Substitute to Autologous Iliac Crest Bone Grafting for Spinal Fusion Procedures in the United StatesSpine, 2011
- Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative DataSpine, 2010
- Donor site morbidity following iliac crest bone harvesting for cervical fusion: a comparison between minimally invasive and open techniquesEuropean Spine Journal, 2008
- Adverse Events in Patients Re-Exposed to Bone Morphogenetic Protein for Spine SurgerySpine, 2008
- Transforaminal Lumbar Interbody FusionJournal of Spinal Disorders & Techniques, 2005
- Contribution of recombinant human bone morphogenetic protein—2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary reportJournal of Neurosurgery: Spine, 2004
- Bone: Formation by AutoinductionScience, 1965